1. Home
  2. WHG vs ANTX Comparison

WHG vs ANTX Comparison

Compare WHG & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$19.20

Market Cap

185.2M

Sector

Finance

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.82

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
ANTX
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.2M
172.9M
IPO Year
2002
2022

Fundamental Metrics

Financial Performance
Metric
WHG
ANTX
Price
$19.20
$4.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
11.0K
★ 225.1K
Earning Date
10-29-2026
11-11-2026
Dividend Yield
★ 3.16%
N/A
EPS Growth
★ 203.85
32.56
EPS
★ 0.25
N/A
Revenue
★ $97,762,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$76.00
★ N/A
Revenue Growth
★ 3.21
N/A
52 Week Low
$14.70
$1.00
52 Week High
$20.97
$7.19

Technical Indicators

Market Signals
Indicator
WHG
ANTX
Relative Strength Index (RSI) 53.40 39.26
Support Level $18.87 $4.61
Resistance Level $20.26 $5.21
Average True Range (ATR) 0.46 0.40
MACD 0.06 0.01
Stochastic Oscillator 72.17 11.76

Price Performance

Historical Comparison
WHG
ANTX

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: